Skip to main content
SpringerLink
Log in

Prognostic value of estrogen and progesterone receptors in primary breast cancer

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Estradiol receptor alone or estradiol and progesterone receptors (ER, PgR) have been measured in tumors from 307 women who were treated for primary breast adenocarcinoma. Patients received adjuvant therapy in relation to tumor stage independently of receptor status. Over a relatively short follow-up, more recurrences are recorded in patients with ER + tumors, but at 7 years the same proportion of recurrences are registered in both groups of patients whose tumors were ER + or ER −. Patients whose tumors were processed for both ER and PgR (148 cases) have now been evaluated after 5 years follow-up. Among 56 patients with PgR + tumors 5 recurred, versus 22/92 in the PgR − group. 21/87 patients who had 1 to 4 invaded nodes at the time of surgery relapsed: 17/54 had PgR − tumors versus 4/33 PgR +. 6 recurrences were recorded in the 61 patients with negative nodes: 5 of them occurred in patients with PgR − tumors. In addition, recurrences observed in patients with negative receptor status occurred after a shorter disease-free interval.

Analysis of the incidence of recurrences in relation to the combined ER/PgR status in patients who did not receive adjuvant therapy suggests that tumor PgR content is a more significant criterion than ER for longterm prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Jensen EV, Block GE, Smith S, Kyser K, DeSombre E: Estrogen receptors and breast cancer response to adrenalectomy. Natl Cancer Inst Monogr 34:55–79, 1971

    PubMed  CAS  Google Scholar 

  2. McGuire WL, Carbone PP, Sears ME, Escher GC: Estrogen receptors in human breast cancer: an overview.In WL McGuire, PP Carbone, and EP Vollmer (eds): Estrogen receptors in human breast cancer. Raven Press, New York, 1975, pp. 1–8

    Google Scholar 

  3. Horwitz KB, McGuire WL, Pearson OH: Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 189:726–727, 1975

    Article  PubMed  CAS  Google Scholar 

  4. McGuire WL: An update on estrogen and progesterone receptors in prognosis for primary and advanced breast cancer. Progr Cancer Res Ther 14:337–343, 1980

    Google Scholar 

  5. Pincus G, Vollmer EP, (eds): Biological activities of steroids in relation to cancer. Academic Press, New York, 1960

    Google Scholar 

  6. TNM classification of malignant tumors: breast, pp. 47–53. Union Internationale Contre le Cancer, Geneve, 1979

  7. Kaplan EL, Meier P: Non parametric estimations from incomplete observations. J Amer Statist Assoc 53:457–481, 1958

    Article  Google Scholar 

  8. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163–170, 1966

    PubMed  CAS  Google Scholar 

  9. Peto R, Pike MC, Armitage P, Breslow NE, Lox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1–39, 1977

    PubMed  CAS  Google Scholar 

  10. EORTC Breast Cancer Cooperative Group: Standards for the assessment of estrogen receptors in human breast cancer. Europ J Cancer 9:379–381, 1973

    Google Scholar 

  11. Saez S, Martin PM, Chouvet CD: Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels. Cancer Res 38:3468, 1978

    PubMed  CAS  Google Scholar 

  12. Saez S, Nassif E, Cheix F, Israel N, Mayer M: Hormone receptors in human breast tumors.In EF Lewison and ACW Montague (eds): Diagnosis and treatment of breast cancer. Williams & Wilkins, Baltimore, 1981, pp. 103–110

    Google Scholar 

  13. Walt AJ, Singhakowinta A, Brooks SC, Cortez A: The surgical implications of estrophile proteins in carcinoma of the breast. Surgery 80:506–512, 1976

    PubMed  CAS  Google Scholar 

  14. Knight WA, Livingston RB, Gregory EJ, McGuire WL: Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37:4669–4671, 1977

    PubMed  CAS  Google Scholar 

  15. Rich MA, Furmanski P, Brooks SC: Prognostic value of estrogen receptor determination in patients with breast cancer. Cancer Res 38:4296–4298, 1978

    PubMed  CAS  Google Scholar 

  16. Hahnel R, Woodings T, Vivian AB: Prognostic value of estrogen receptors in primary breast cancer. Cancer 44:671–675, 1979

    Article  PubMed  CAS  Google Scholar 

  17. Allegra JC, Lippman ME: Estrogen receptor status and the disease free interval in breast cancer. Rec Results Cancer Res 71:20–25, 1980

    CAS  Google Scholar 

  18. Bishop HM, Blamey RW, Elston CW, Haybittle JL, Nicholson RI, Griffiths K: Relationship of estrogen receptor status to survival in breast cancer. Lancet ii:283–284, 1979

    Article  Google Scholar 

  19. Furmanski P, Saunders DE, Brooks SC, Rich MA: The prognostic value of estrogen receptor determinations in patients with primary breast cancer: an update. Cancer 46:2794–2796, 1980

    Article  PubMed  CAS  Google Scholar 

  20. Westerberg H, Gustafsson SA, Nordenskjold R, Silfversward C, Wallgren A: Estrogen receptor level and other factors in early recurrence of breast cancer. Int J Cancer 26:429–438, 1980

    PubMed  CAS  Google Scholar 

  21. Croton R, Cooke T, Holt S, George WD, Nicolson P, Griffiths K: Estrogen receptors and survival in early breast cancer. Br Med J 283:1289–1291, 1981

    Article  CAS  Google Scholar 

  22. Kinne DW, Ashikari R, Butler A, Menendez-Botet C, Rosen PP, Schwartz M: Estrogen receptor protein in breast cancer as a predictor of recurrence. Cancer 47:2364–2367, 1981

    Article  PubMed  CAS  Google Scholar 

  23. Hilf R, Feldstein ML, Gibson SL, Savlov ED: The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer. Cancer 45:1993–2000, 1980

    Article  PubMed  CAS  Google Scholar 

  24. Hubay CA, Pearson OH, Marshall JS, Stellato TA, Rhodes RS, De Banne SM, Rosenblatt J, Mansour EG, Hermann RE, Jones JC, Flynn WJ, Eckert C, McGuire WL: Adjuvant therapy of stage II breast cancer: 48 months follow up of prospective randomized trial. Breast Cancer Res Treat 1:77–82, 1981

    Article  PubMed  CAS  Google Scholar 

  25. Crowe JP, Hubay CA, Pearson OH, Marshall JS, Rosenblatt J, Mansour EG, Hermann RE, Jones JC, Flynn WJ, McGuire WL: Estrogen receptor status as a prognostic factor for stage I breast cancer patients. Breast Cancer Res Treat 2:171–176, 1982

    Article  PubMed  CAS  Google Scholar 

  26. DeSombre ER, Jensen EV: Estrophilin assays in breast cancer: quantitative features and application to the mastectomy specimen. Cancer 46:2783–2788, 1980

    Article  PubMed  CAS  Google Scholar 

  27. Paridaens R, Sylvester RJ, Ferrazi E, Legros N, Leclercq G, Heuson JC: Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer. Cancer 46:2889–2895, 1980

    Article  PubMed  CAS  Google Scholar 

  28. Godolphin W, Elwood JM, Spinelli JJ: Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: a study of 583 patients. Int J Cancer 28:677–683, 1981

    PubMed  CAS  Google Scholar 

  29. Martin PM, Jaquemier J, Rolland P, Rolland AM, Toga M: Human mammary carcinoma: relationship between steroid hormone receptors and histopathology. An hypothesis, the prognostic value of hormone receptors. Bull Cancer 65:383–387, 1978

    PubMed  CAS  Google Scholar 

  30. McGuire WL: Steroid hormone receptors in breast cancer treatment strategy. Rec Progr Hormone Res 36:135–146, 1980

    CAS  Google Scholar 

  31. Pichon MF, Pallud C, Brunet M, Milgrom E: Relationship of presence of progesterone receptors to prognosis in early breast cancer. Cancer Res 40:3357–3360, 1980

    PubMed  CAS  Google Scholar 

  32. Saez S, Chouvet C, Mayer M, Cheix F: Estradiol and progesterone receptors as prognostic factors in human primary breast tumors. Proc Am Assoc Cancer Res 21:139, 1980

    Google Scholar 

  33. Saez S, Pichon MF, Cheix F, Mayer M, Pallud C, Brunet M, Milgrom E: Progesterone receptors and prognosis in early breast cancer. The experience of two Centers.In Bardin, Mauvais-Jarvis, and Milgrom (eds): Progesterone and Progestins. Raven Press 1983 pp 355–366

  34. Allegra JC, Lippman ME, Simon R, Thompson EB, Barlock A, Green L, Huff KK, Do HMT, Aitken SC, Warren R: Association between steroid hormone receptor status and disease free interval in breast cancer. Cancer Treat Rep 63:1271–1277, 1979

    PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Simone Saez

    Present address: Centre Léon Bérard, Lyon, France

Authors and Affiliations

  1. Centre Léon Bérard, Lyon, France

    Françoise Cheix

  2. Fondation Curie, Paris, France

    Bernard Asselain

Authors
  1. Simone Saez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Françoise Cheix
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bernard Asselain
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saez, S., Cheix, F. & Asselain, B. Prognostic value of estrogen and progesterone receptors in primary breast cancer. Breast Cancer Res Tr 3, 345–353 (1983). https://doi.org/10.1007/BF01807587

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01807587

Keywords

Search

Navigation